OpGen, Inc. (OPGN): Price and Financial Metrics


OpGen, Inc. (OPGN): $1.86

-0.03 (-1.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OPGN POWR Grades


  • OPGN scores best on the Sentiment dimension, with a Sentiment rank ahead of 92.02% of US stocks.
  • OPGN's strongest trending metric is Momentum; it's been moving down over the last 52 weeks.
  • OPGN ranks lowest in Stability; there it ranks in the 3rd percentile.

OPGN Stock Summary

  • Opgen Inc's market capitalization of $73,478,880 is ahead of just 10.43% of US-listed equities.
  • OPGN's price/sales ratio is 18.14; that's higher than the P/S ratio of 89.31% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for OPGN comes in at -62.83% -- higher than that of only 4.41% of stocks in our set.
  • Stocks that are quantitatively similar to OPGN, based on their financial statements, market capitalization, and price volatility, are ASX, EMAN, ACUR, GOVX, and ATNX.
  • OPGN's SEC filings can be seen here. And to visit Opgen Inc's official web site, go to www.opgen.com.

OPGN Valuation Summary

  • OPGN's EV/EBIT ratio is -3.6; this is 112.29% lower than that of the median Healthcare stock.
  • OPGN's price/sales ratio has moved up 17.6 over the prior 77 months.
  • Over the past 77 months, OPGN's price/sales ratio has gone up 17.6.

Below are key valuation metrics over time for OPGN.

Stock Date P/S P/B P/E EV/EBIT
OPGN 2021-08-31 30.2 3.1 -3.3 -3.6
OPGN 2021-08-30 28.0 2.9 -3.1 -3.4
OPGN 2021-08-27 29.1 3.0 -3.2 -3.5
OPGN 2021-08-26 29.5 3.0 -3.3 -3.5
OPGN 2021-08-25 26.8 2.7 -3.0 -3.2
OPGN 2021-08-24 27.6 2.8 -3.0 -3.3

OPGN Growth Metrics

  • Its year over year revenue growth rate is now at 43.03%.
  • Its 3 year net cashflow from operations growth rate is now at 27.69%.
  • Its 5 year net income to common stockholders growth rate is now at 28.72%.
OPGN's revenue has moved up $892,734 over the prior 67 months.

The table below shows OPGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 4.050454 -26.723 -36.72306
2021-03-31 4.427224 -26.01772 -37.11214
2020-12-31 4.214441 -23.39653 -26.21084
2020-09-30 3.682757 -19.90764 -21.61842
2020-06-30 3.274212 -14.91402 -17.42526
2020-03-31 3.09537 -10.8644 -12.54264

OPGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OPGN has a Quality Grade of D, ranking ahead of 5.88% of graded US stocks.
  • OPGN's asset turnover comes in at 0.068 -- ranking 75th of 81 Healthcare stocks.
  • PMD, MGLN, and THC are the stocks whose asset turnover ratios are most correlated with OPGN.

The table below shows OPGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.068 0.109 -1.125
2021-03-31 0.082 0.075 -1.281
2020-12-31 0.105 0.087 -1.177
2020-09-30 0.122 0.118 -1.429
2020-06-30 0.158 0.329 -1.982
2020-03-31 0.272 0.457 -3.454

OPGN Price Target

For more insight on analysts targets of OPGN, see our OPGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.00 Average Broker Recommendation 1.5 (Moderate Buy)

OPGN Stock Price Chart Interactive Chart >

Price chart for OPGN

OPGN Price/Volume Stats

Current price $1.86 52-week high $4.37
Prev. close $1.89 52-week low $1.63
Day low $1.80 Volume 1,910,100
Day high $1.88 Avg. volume 4,741,031
50-day MA $2.74 Dividend yield N/A
200-day MA $2.49 Market Cap 71.18M

OPGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OPGN Latest Social Stream


Loading social stream, please wait...

View Full OPGN Social Stream

Latest OPGN News From Around the Web

Below are the latest news stories about Opgen Inc that investors may wish to consider to help them evaluate OPGN as an investment opportunity.

OpGen Subsidiary Ares Genetics Launches AREScloud

AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolatesAREScloud offers an advanced solution for infection prevention and control ROCKVILLE, Md., Oct. 21, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that its subsidiary Ares Genetics, which strives to become a leader in bacterial gen

Yahoo | October 21, 2021

OpGen Announces Closing of $15 Million Registered Direct Offering

ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor of 150,000 shares of convertible preferred stock and warrants to purchase up to an aggregate of 7,500,000 shares of common stock

Yahoo | October 18, 2021

OpGen Announces $15 Million Registered Direct Offering

ROCKVILLE, Md., Oct. 14, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of an aggregate of 150,000 shares of convertible preferred stock and warrants to purchase up to an aggregate of 7,500,000

Yahoo | October 14, 2021

44 Biggest Movers From Yesterday

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints. Elmira Savings Bank (NASDAQ: ESBK) gained 68.2% to close at $22.70 after the company announced it would be acquired by Community Bank System. Mexco Energy Corporation (NYSE: MXC) rose 46.4% to settle at $16.97 after OPEC+ agreed to stay with an existing pact to increase

Yahoo | October 5, 2021

Rockville biotech lands federal approval for superbug testing system

The diagnostic aims to help doctors recognize drug resistance early in infections to help inform treatment decisions.

Yahoo | October 4, 2021

Read More 'OPGN' Stories Here

OPGN Price Returns

1-mo -39.02%
3-mo -17.33%
6-mo -21.19%
1-year -20.85%
3-year -92.50%
5-year -99.68%
YTD -8.82%
2020 80.53%
2019 -95.65%
2018 -72.19%
2017 -83.74%
2016 -39.47%

Continue Researching OPGN

Want to see what other sources are saying about Opgen Inc's financials and stock price? Try the links below:

Opgen Inc (OPGN) Stock Price | Nasdaq
Opgen Inc (OPGN) Stock Quote, History and News - Yahoo Finance
Opgen Inc (OPGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9046 seconds.